Ana Gelatti

8PUBLICATIONS
54CO-AUTHORS
Oncology and carcinogenesis not elsewhere classifiedCancer diagnosisCancer cell biologyWomen's studies (incl. girls' studies)Cancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (8)

|Jun 24, 2026
Treatment of ALK+ Non-Small Cell Lung Cancer in the Brazilian Public and Private Health Care Systems: A Tale of Inequalities (LACOG/GBOT 1918).

|Jun 04, 2026
Current Access to Anaplastic Lymphoma Kinase Testing and Targeted Therapies for Non-Small Cell Lung Cancer in Brazil: Results From a Cross-Sectional Survey (LACOG 1224-GBOT).

|Mar 26, 2026
Lung Cancer in Women in Brazil: Incidence, Trends, and Overlooked Risk Factors.

Eldsamira Mascarenhas, Cinthya Sternberg, Sofia Vidaurre

|Apr 23, 2025
Gender Equity and Workplace Mistreatment in Oncology: Results From a Survey by the Brazilian Society of Clinical Oncology.

Daniele Assad Suzuki, Maria de Fatima Dias Gaui, Daniela Dornelles Rosa

|Jan 15, 2025
Durvalumab as consolidation therapy in patients who received chemoradiotherapy for unresectable stage III NSCLC: Real-world data from an expanded access program in Brazil (LACOG 0120).

Mauro Zukin, Victor Gondim, Andrea Kazumi Shimada

|Jul 18, 2024
PACIFIC-9: Phase III trial of durvalumab + oleclumab or monalizumab in unresectable stage III non-small-cell lung cancer.

Fabrice Barlesi, Byoung Chul Cho, Sarah B Goldberg

Pageof 2

Frequent Collaborators

5 joint publications

Eldsamira Mascarenhas

4 joint publications

Clarissa Baldotto

2 joint publications

Mauro Zukin

2 joint publications

William Nassib William Junior